- All sections
- C - Chemistrymetallurgy
- C07K - Peptides
- C07K 16/16 - Immunoglobulins, e.g. monoclonal or polyclonal antibodies against material from plants
Patent holdings for IPC class C07K 16/16
Total number of patents in this class: 286
10-year publication summary
|
23
|
27
|
20
|
8
|
19
|
15
|
19
|
21
|
18
|
15
|
| 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
Principal owners for this class
| Owner |
All patents
|
This class
|
|---|---|---|
| Mabylon AG | 24 |
16 |
| Regeneron Pharmaceuticals, Inc. | 4887 |
15 |
| Vanderbilt University | 2035 |
8 |
| Hoffmann-La Roche Inc. | 3876 |
7 |
| IgGenix, Inc. | 16 |
7 |
| Northern Bank Limited | 69 |
6 |
| Her Majesty the Queen in Right of Canada, as represented by the Minister of National Defence | 201 |
5 |
| The Board of Regents of the University of Texas System | 2313 |
5 |
| CZ Biohub Sf, LLC | 161 |
5 |
| Pioneer Hi-Bred International, Inc. | 7131 |
4 |
| The General Hospital Corporation | 4903 |
4 |
| Biostrategies LC | 14 |
4 |
| Taisho Pharmaceutical Co., Ltd. | 850 |
4 |
| Seoul National University R&db Foundation | 4281 |
4 |
| NIMA Partners, Inc. | 26 |
4 |
| F. Hoffmann-La Roche AG | 7784 |
3 |
| Glaxosmithkline Intellectual Property Development Limited | 783 |
3 |
| Massachusetts Institute of Technology | 10324 |
3 |
| Japan Science and Technology Agency | 1207 |
3 |
| Agrosavfe N.V. | 9 |
3 |
| Other owners | 173 |